Life sciences company Quick-Med Technologies has received notice of allowance for additional new US patent protecting new, non-leaching Nimbus antimicrobial technology.
A total of 41 claims were allowed by the US Patent and Trademark Office in patent application entitled, 'Polyelectrolyte Complex For Imparting Antimicrobial Properties To A Substrate.'
Quick-Med R&D vice-president Dr William Toreki said the PEC method is an important improvement in the way the company manufactures NIMBUS materials.
"The PEC makes the antimicrobial component more adherent on a molecular level, and that makes it easier to attach it to the surfaces of bandages and wound dressings," Toreki added.
Improved method of preparing the company's NIMBUS antimicrobial products, using Poly-Electrolyte Complex (PEC), will be protected through the patent.
In PEC, a negatively-charged (anionic) polymer is used to stabilize the active antimicrobial agent that is a positively-charged (cationic)polymer allowing the NIMBUS polymer to be bonded to a range of substrates.
